Revenue Growth and Improved Margins
For the third quarter, revenue increased by 2.5% year-over-year, with a 5.6% increase year-to-date. Gross margins improved by 16%, operating loss narrowed with a 92% improvement, and adjusted EBITDA increased by 42% compared to the previous year.
Significant Growth in New Markets
The new radiation therapy treatment center in Puebla, Mexico, reported a 263% annual revenue growth. Additionally, the company saw a 9.4% increase in revenue from its Direct Patient Services segment.
Expansion and New Facilities
Plans to open a Gamma Knife Center in Guadalajara, Mexico, were announced, and the acquisition of three Rhode Island cancer treatment centers is contributing to increased patient consultations and treatment volumes.